News
A recently launched video series from the Biotechnology Innovation Organization (BIO) seeks to show how biotech may be able ...
Indiana Attorney General Todd Rokita has secured $720 million in settlements with eight drug makers that manufacture opioid ...
Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir. Aurobindo, Cipla and ...
Viatris in Egypt, a part of global healthcare company Viatris, announced the launch of Norvasc Val, a combination therapy for ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
4d
Pharmaceutical Technology on MSNNovo Nordisk defeated in Wegovy patent dispute by ViatrisThe Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Michael Goettler and Sa ...
Shares of Viatris Inc. VTRS advanced 1.41% to $9.37 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.78% to 6,358.91 and ...
Attorney General Alan Wilson announced approximately $720 million nationwide in settlements with eight drug makers that ...
Viatris Inc.'s proposed copy of Novo Nordisk A/S’ Wegovy doesn’t infringe a patent on using the once-weekly obesity drug ...
Viatris offers value with high free cash flow and dividends but faces growth challenges from legacy drug price erosion and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results